Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial

Conditions: Meningioma Interventions: Drug: Everolimus Sponsors: Central Hospital, Nancy, France Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials